Skip to content

QUIDDITAS

Active
Public limited companyfounded 20223 yrs activeAvenue Hippocrate 5, 4000 Liège, BelgiumKBO/BCE: BE 0794.472.362
Summary

QUIDDITAS has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €127,985. Equity is growing by ~461.8% per year across the filed fiscal years. Its solvency ranks better than 90% of 197 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Risk analysisWatch ReportCompare
QUIDDITASActiveChecked score 88/100
Risk analysis ReportCompare

Overview

What they do
Research and development on biotechnology
NACE 72101NACE 72110
1 site
How big
€1.2mtotal assets 2025
Staff
1 FTE
Equity
€1.1m
Profit
€127,985
Financially healthy?
88 Excellent Checked score 2025
Bankruptcy chance 12 m
0.7%
Who decides
Holdings
1
Accounts 50 d early0 of 4 deeds read
Why 88- Limited track record- Higher-failure-rate region+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Lower-risk legal formLatest accounts filed on timeShow the evidence

Checked score

Score 2025
88 / 100
Excellent
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82▲+82
Solvency100▲+4
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100,000 at 30 days acceptable
Liquidity ample (current ratio 19.81 against 0.01 in 2024; short-term debt: 3.3% and cash: 63.2% of total assets), and 3.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
96.7%
Return on assets
10.8%
Age of the figures
9 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
50 d early
2024
51 d early
2023
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 34 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 June (3 of the last 3 filed years within 51 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Back to profitnet €127,985
  3. Liquidity times 1469current ratio 19.81

Key points

  • Positive: Equity rose in 2025from €117,734 to €1.1m ▲ 873% View
  • Positive: Among the best 11% on solvencysector median 52.1% · 197 companies 96.7% View
  • Total assets 20253 fiscal years filed €1.2m View

By topic

Financials

Fiscal year
2025
Total assets
€1.2m
Profit
€127,985
Solvency
96.7%
Total assets▲ 612%
Net result
20232025
Go to Financials

Timeline

Events
8
Since
2024
Next accounts
by 31-07-2027
  1. 11-06-2026Annual accounts filed
  2. 31-12-2025Back to profit
  3. 31-12-2025Liquidity times 1469
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
06-12-2022
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure